Bhaskar Saha Selected Research

Immunotherapy

9/2022	Immunotherapy for visceral leishmaniasis: A trapeze of balancing counteractive forces.
1/2020	Immunostimulatory effect of chitosan conjugated green copper oxide nanoparticles in tumor immunotherapy.
1/2018	DAMP-TLR-cytokine axis dictates the fate of tumor.
1/2015	Iron, inflammation and invasion of cancer cells.
2/2013	IL-27 in tumor immunity and immunotherapy.
10/2006	Inhibition of IL-2 induced IL-10 production as a principle of phase-specific immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bhaskar Saha Research Topics

Disease

41	Infections 12/2021 - 07/2002
25	Leishmaniasis 01/2022 - 05/2004
23	Neoplasms (Cancer) 01/2022 - 11/2006
11	Visceral Leishmaniasis (Kala Azar) 09/2022 - 05/2006
5	Inflammation (Inflammations) 01/2021 - 01/2015
4	Communicable Diseases (Infectious Diseases) 01/2022 - 07/2010
4	Melanoma (Melanoma, Malignant) 01/2022 - 11/2018
3	Lung Neoplasms (Lung Cancer) 11/2018 - 10/2016
3	Neoplasm Metastasis (Metastasis) 11/2018 - 01/2015
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2020
2	Malaria 01/2021 - 01/2019
2	Septic Shock (Toxic Shock Syndrome) 12/2009 - 06/2008
1	Chronic Disease (Chronic Diseases) 10/2022
1	Drug-Related Side Effects and Adverse Reactions 09/2022
1	Carcinogenesis 01/2022
1	Rheumatoid Arthritis 01/2022
1	Trypanosomiasis 01/2022
1	Tuberculosis (Tuberculoses) 01/2022
1	Persistent Infection 12/2021
1	Poliomyelitis (Polio) 12/2021
1	Demyelinating Diseases (Demyelinating Disease) 12/2021
1	Asthma (Bronchial Asthma) 02/2021
1	Hypersensitivity (Allergy) 02/2021
1	Allergic Rhinitis 02/2021
1	COVID-19 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Parasitemia 01/2021
1	Genomic Instability 01/2021
1	Cytokine Release Syndrome 09/2020

Drug/Important Bio-Agent (IBA)

21	Interleukin-10 (Interleukin 10)IBA 12/2021 - 05/2004
18	CytokinesIBA 10/2022 - 05/2004
11	Interleukin-12 (IL 12)IBA 01/2022 - 11/2006
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2007
7	Pharmaceutical PreparationsIBA 09/2022 - 04/2013
6	VaccinesIBA 01/2022 - 11/2011
6	LigandsIBA 01/2022 - 10/2014
6	Interleukin-4 (Interleukin 4)IBA 01/2021 - 06/2004
5	Protein Isoforms (Isoforms)IBA 10/2021 - 03/2012
4	Interleukin-27 (Interleukin 27)IBA 01/2022 - 02/2013
4	CD40 Ligand (CD40L)IBA 12/2021 - 02/2007
4	ChemokinesIBA 01/2021 - 08/2017
4	Phosphotransferases (Kinase)IBA 01/2020 - 11/2011
3	InterleukinsIBA 01/2020 - 12/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2011
3	Dual-Specificity PhosphatasesIBA 01/2018 - 05/2011
3	Interleukin-2 (IL2)IBA 11/2016 - 10/2006
2	CholesterolIBA 10/2022 - 03/2009
2	InflammasomesIBA 10/2022 - 01/2015
2	Small Interfering RNA (siRNA)IBA 01/2022 - 03/2012
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 01/2021
2	AlkaloidsIBA 12/2021 - 07/2017
2	BerberineIBA 12/2021 - 07/2017
2	Neoplasm Antigens (Tumor Antigens)IBA 12/2021 - 10/2014
2	Antimalarials (Antimalarial Agents)IBA 01/2021 - 01/2021
2	InterferonsIBA 01/2021 - 10/2014
2	Oxidoreductases (Dehydrogenase)IBA 08/2020 - 12/2017
2	Amino Acids FDA Link 08/2020 - 01/2020
2	AutoantigensIBA 08/2020 - 01/2018
2	Peptides (Polypeptides)IBA 08/2020 - 10/2019
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2020 - 04/2003
2	miltefosine (Impavido)IBA 01/2020 - 06/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2018
2	AntigensIBA 10/2019 - 01/2015
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2019 - 11/2018
2	artemisinin (artemisinine)IBA 01/2019 - 11/2018
2	Glucose (Dextrose)FDA LinkGeneric 12/2018 - 10/2016
2	SurvivinIBA 11/2018 - 11/2018
2	ResveratrolIBA 11/2018 - 09/2017
2	AntimonyIBA 09/2015 - 05/2006
2	lipoarabinomannan (LAM)IBA 01/2015 - 07/2010
2	Toll-Like Receptor 2IBA 01/2015 - 07/2010
2	Enterotoxins (Enterotoxin)IBA 12/2009 - 06/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2008 - 11/2006
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Imiquimod (Aldara)FDA LinkGeneric 01/2022
1	Granzymes (Granzyme)IBA 01/2022
1	Conditioned Culture MediaIBA 12/2021
1	Protein Kinase CIBA 10/2021
1	AllergensIBA 02/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	talazoparibIBA 01/2021
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021
1	Interferon LambdaIBA 01/2021
1	ZymosanIBA 12/2020
1	Polysaccharides (Glycans)IBA 12/2020
1	dectin 1IBA 12/2020
1	GlucansIBA 12/2020
1	Nimodipine (Modus)FDA LinkGeneric 12/2020
1	LectinsIBA 12/2020
1	ArginaseIBA 08/2020
1	Histocompatibility Antigens (Histocompatibility Antigen)IBA 08/2020

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 09/2022 - 05/2006
6	Immunotherapy 09/2022 - 10/2006
6	Therapeutics 01/2021 - 07/2010
2	Immunomodulation 12/2020 - 01/2018
1	Traditional Medicine (Folk Remedies) 01/2022
1	Radiotherapy 01/2021
1	Oral Administration 01/2021